Sanofi-GSK reports success in Covid-19 vaccine, after setback

The drugmakers said they plan to begin late-stage trials and production in the coming weeks and hope to win regulatory approval for the vaccine before the end of 2021.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tTpvFg
via IFTTT